Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology

Neurodegenerative dementias are the most common group of neurodegenerative diseases affecting more than 40 million people worldwide. One of these diseases is frontotemporal dementia (FTD), an early onset dementia and one of the leading causes of dementia in people under the age of 60. FTD is a heter...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rebekka Kühn, Aayushi Mahajan, Peter Canoll, Gunnar Hargus
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
tau
Acceso en línea:https://doaj.org/article/18ebd0a1b7c642c4ba21658bca7a396c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:18ebd0a1b7c642c4ba21658bca7a396c
record_format dspace
spelling oai:doaj.org-article:18ebd0a1b7c642c4ba21658bca7a396c2021-11-10T06:12:54ZHuman Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology2296-634X10.3389/fcell.2021.766773https://doaj.org/article/18ebd0a1b7c642c4ba21658bca7a396c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.766773/fullhttps://doaj.org/toc/2296-634XNeurodegenerative dementias are the most common group of neurodegenerative diseases affecting more than 40 million people worldwide. One of these diseases is frontotemporal dementia (FTD), an early onset dementia and one of the leading causes of dementia in people under the age of 60. FTD is a heterogeneous group of neurodegenerative disorders with pathological accumulation of particular proteins in neurons and glial cells including the microtubule-associated protein tau, which is deposited in its hyperphosphorylated form in about half of all patients with FTD. As for other patients with dementia, there is currently no cure for patients with FTD and thus several lines of research focus on the characterization of underlying pathogenic mechanisms with the goal to identify therapeutic targets. In this review, we provide an overview of reported disease phenotypes in induced pluripotent stem cell (iPSC)-derived neurons and glial cells from patients with tau-associated FTD with the aim to highlight recent progress in this fast-moving field of iPSC disease modeling. We put a particular focus on genetic forms of the disease that are linked to mutations in the gene encoding tau and summarize mutation-associated changes in FTD patient cells related to tau splicing and tau phosphorylation, microtubule function and cell metabolism as well as calcium homeostasis and cellular stress. In addition, we discuss challenges and limitations but also opportunities using differentiated patient-derived iPSCs for disease modeling and biomedical research on neurodegenerative diseases including FTD.Rebekka KühnAayushi MahajanPeter CanollGunnar HargusGunnar HargusFrontiers Media S.A.articlefrontotemporal dementia (FTD)induced pluriopotent stem cellstaudisease modelingfrontotemporal lobar degeneration (FTLD)neurodegenenerative diseasesBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic frontotemporal dementia (FTD)
induced pluriopotent stem cells
tau
disease modeling
frontotemporal lobar degeneration (FTLD)
neurodegenenerative diseases
Biology (General)
QH301-705.5
spellingShingle frontotemporal dementia (FTD)
induced pluriopotent stem cells
tau
disease modeling
frontotemporal lobar degeneration (FTLD)
neurodegenenerative diseases
Biology (General)
QH301-705.5
Rebekka Kühn
Aayushi Mahajan
Peter Canoll
Gunnar Hargus
Gunnar Hargus
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
description Neurodegenerative dementias are the most common group of neurodegenerative diseases affecting more than 40 million people worldwide. One of these diseases is frontotemporal dementia (FTD), an early onset dementia and one of the leading causes of dementia in people under the age of 60. FTD is a heterogeneous group of neurodegenerative disorders with pathological accumulation of particular proteins in neurons and glial cells including the microtubule-associated protein tau, which is deposited in its hyperphosphorylated form in about half of all patients with FTD. As for other patients with dementia, there is currently no cure for patients with FTD and thus several lines of research focus on the characterization of underlying pathogenic mechanisms with the goal to identify therapeutic targets. In this review, we provide an overview of reported disease phenotypes in induced pluripotent stem cell (iPSC)-derived neurons and glial cells from patients with tau-associated FTD with the aim to highlight recent progress in this fast-moving field of iPSC disease modeling. We put a particular focus on genetic forms of the disease that are linked to mutations in the gene encoding tau and summarize mutation-associated changes in FTD patient cells related to tau splicing and tau phosphorylation, microtubule function and cell metabolism as well as calcium homeostasis and cellular stress. In addition, we discuss challenges and limitations but also opportunities using differentiated patient-derived iPSCs for disease modeling and biomedical research on neurodegenerative diseases including FTD.
format article
author Rebekka Kühn
Aayushi Mahajan
Peter Canoll
Gunnar Hargus
Gunnar Hargus
author_facet Rebekka Kühn
Aayushi Mahajan
Peter Canoll
Gunnar Hargus
Gunnar Hargus
author_sort Rebekka Kühn
title Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
title_short Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
title_full Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
title_fullStr Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
title_full_unstemmed Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
title_sort human induced pluripotent stem cell models of frontotemporal dementia with tau pathology
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/18ebd0a1b7c642c4ba21658bca7a396c
work_keys_str_mv AT rebekkakuhn humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology
AT aayushimahajan humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology
AT petercanoll humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology
AT gunnarhargus humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology
AT gunnarhargus humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology
_version_ 1718440445910974464